| Not Yet Recruiting | Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Sp NCT07479199 | UNC Lineberger Comprehensive Cancer Center | — |
| Recruiting | Post-operative Medium Chain Triglyceride Diet May Reduce Hospital Stay Following Lung Resection NCT07159659 | Chinese University of Hong Kong | N/A |
| Recruiting | Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients NCT07242547 | Fundación GECP | Phase 2 |
| Recruiting | Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy NCT07205536 | Affiliated Hospital of Nantong University | Phase 2 |
| Recruiting | PALACE: Cemiplimab Trial According to ctDNA Levels NCT06917573 | Fundación GECP | Phase 2 |
| Not Yet Recruiting | Optimizing Radiation Dose and Utilizing Wearable Devices to Reduce Arrhythmia Risk in Patients Undergoing Thor NCT06897189 | Yonsei University | — |
| Recruiting | Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer NCT06758700 | Shanghai Pulmonary Hospital, Shanghai, China | Phase 2 |
| Active Not Recruiting | Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study NCT06494241 | AstraZeneca | — |
| Completed | SPSIPB vs SAPB for Thoracoscopic Surgery NCT06546839 | Medipol University | N/A |
| Active Not Recruiting | Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC NCT06376084 | AstraZeneca | — |
| Recruiting | Early Intervention Strategies for Lung Cancer NCT06988943 | The First Affiliated Hospital of Guangzhou Medical University | N/A |
| Recruiting | A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-S NCT06177925 | Nanfang Hospital, Southern Medical University | Phase 2 |
| Recruiting | The Effects of a Family-Centered Tai Chi Exercise on Lung Function and Mental Health of Patients After Thoraco NCT06104774 | China Medical University Hospital | N/A |
| Completed | Comparison of Ultrasound, CT, and Classical Methods for Selecting Sizes and Placement of Left-Sided Double-Lum NCT06731517 | Ankara City Hospital Bilkent | — |
| Recruiting | Real World Registry for Use of the Ion Endoluminal System NCT06004440 | Intuitive Surgical | — |
| Completed | Pain Control After VATS Anatomical Pulmonary Resections NCT05993273 | University Hospital Padova | N/A |
| Recruiting | Erector Spinae Block for Thoracic Surgery NCT05521789 | George Washington University | Phase 4 |
| Unknown | Comparison Between McGrath and Macintosh Laryngoscopes for DLT Intubation in Thoracic Surgery Patients. NCT05988736 | Aga Khan University | N/A |
| Terminated | (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC NCT05153408 | Blueprint Medicines Corporation | Phase 1 |
| Completed | mHealth ALIBIRD: A Digital Health Care Model NCT05770869 | Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares | N/A |
| Terminated | (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC NCT04862780 | Blueprint Medicines Corporation | Phase 1 |
| Active Not Recruiting | Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) NCT04776447 | Fundación GECP | Phase 2 |
| Terminated | A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic NCT04644315 | Hoffmann-La Roche | Phase 2 |
| Unknown | Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarco NCT04725448 | Sichuan Cancer Hospital and Research Institute | Phase 2 |
| Unknown | External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patien NCT04697446 | Blueprint Medicines Corporation | — |
| Completed | Improving Cancer On-treatment Symptom Management NCT04589247 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Completed | Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under NCT04556344 | University Hospital, Lille | N/A |
| Completed | Erector Spinae Block for Thoracoscopic Surgery NCT04751552 | St. Antonius Hospital | N/A |
| Completed | Role of Ultrasound Guided Peripheral Thoracic Tumors NCT04741958 | Beni-Suef University | N/A |
| Terminated | A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer NCT04222972 | Hoffmann-La Roche | Phase 3 |
| Unknown | Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC NCT04371796 | Sichuan Cancer Hospital and Research Institute | Phase 2 |
| Unknown | Integrated Care Pathway in Oncology (PASSION) NCT04235556 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Studying a New Piece of Equipment That Can Help Plan Radiation Therapy of the Spine NCT04227717 | Memorial Sloan Kettering Cancer Center | N/A |
| Unknown | Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC NCT04133337 | Sichuan Cancer Hospital and Research Institute | Phase 1 / Phase 2 |
| Unknown | Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC NCT03389256 | Sichuan Cancer Hospital and Research Institute | Phase 2 |
| Unknown | Radiotherapy Treatments for the Treatment of Thoracic District Tumors NCT06335290 | European Institute of Oncology | — |
| Terminated | Educational Intervention to Increase the Emotional Competence of Patients With Oesogastric and Bronchopulmonar NCT03306693 | University Hospital, Lille | N/A |
| Completed | A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC NCT03134872 | Jiangsu HengRui Medicine Co., Ltd. | Phase 3 |
| Unknown | International Lung Screen Trial (ILST) NCT02871856 | The University of Queensland | N/A |
| Completed | Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Can NCT03037385 | Hoffmann-La Roche | Phase 1 / Phase 2 |
| Completed | Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors NCT02909452 | Syndax Pharmaceuticals | Phase 1 |
| Completed | Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors NCT02897778 | Syndax Pharmaceuticals | Phase 1 |
| Unknown | Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA NCT02833467 | Peking University People's Hospital | — |
| Completed | A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers NCT02188563 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | N/A |
| Terminated | A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy NCT02111824 | The Methodist Hospital Research Institute | Phase 1 |
| Unknown | Monitoring Radiobiological Effects in Thoracic Malignancy by Using Myocardial Perfusion Scan NCT01913769 | Far Eastern Memorial Hospital | — |
| Unknown | The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial NCT03402048 | University of Turin, Italy | Phase 3 |
| Completed | Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations NCT01024413 | Chinese Society of Lung Cancer | Phase 3 |
| Completed | Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer NCT00880971 | Chinese Academy of Medical Sciences | Phase 3 |
| Completed | Thoracic OncoGeriatric Assessment (TOGA) Trials NCT00591981 | University of Wisconsin, Madison | — |
| Completed | Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients NCT00437372 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 1 |
| Completed | Follow-up Modalities of Low Grade Precancerous Bronchial Lesions NCT00213603 | University Hospital, Rouen | — |
| Unknown | Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury NCT00631839 | Shanghai Cancer Hospital, China | — |
| No Longer Available | Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC NCT06841874 | Nuvation Bio Inc. | — |